The present invention relates generally to hydrolyzable drug-oligomer conjugates,
pharmaceutical compositions comprising such conjugates, and to methods for making
and using such conjugates and pharmaceutical compositions. For example, a conjugate
of insulin, PEG, and oleic acid can be orally administered.